Simplex Trading’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $336K | Buy |
+6,500
| New | +$331K | ﹤0.01% | 3696 |
|
|
2025
Q1 | – | Sell |
-500
| Closed | -$18K | – | 9642 |
|
|
2024
Q4 | $18K | Buy |
500
+400
| +400% | +$14.1K | ﹤0.01% | 6781 |
|
|
2024
Q3 | $3K | Hold |
100
| – | – | ﹤0.01% | 7893 |
|
|
2024
Q2 | $2K | Sell |
100
-4,800
| -98% | -$139K | ﹤0.01% | 8352 |
|
|
2024
Q1 | $167K | Buy |
4,900
+600
| +14% | +$17.9K | ﹤0.01% | 5050 |
|
|
2023
Q4 | $124K | Buy |
+4,300
| New | +$114K | ﹤0.01% | 5159 |
|
|
2022
Q4 | – | Sell |
-100
| Closed | -$3K | – | 10388 |
|
|
2022
Q3 | $3K | Sell |
100
-200
| -67% | -$6.51K | ﹤0.01% | 9156 |
|
|
2022
Q2 | $8K | Sell |
300
-800
| -73% | -$22.9K | ﹤0.01% | 8499 |
|
|
2022
Q1 | $35K | Sell |
1,100
-2,600
| -70% | -$79.7K | ﹤0.01% | 7611 |
|
|
2021
Q4 | $107K | Buy |
3,700
+900
| +32% | +$27.3K | ﹤0.01% | 6152 |
|
|
2021
Q3 | $87K | Hold |
2,800
| – | – | ﹤0.01% | 6814 |
|
|
2021
Q2 | $86K | Buy |
+2,800
| New | +$85.8K | ﹤0.01% | 6949 |
|
|
2021
Q1 | – | Sell |
-9
| Closed | -$22K | – | 9984 |
|
|
2020
Q4 | $22K | Sell |
9
-65
| -88% | -$1.4K | ﹤0.01% | 6919 |
|
|
2020
Q3 | $154K | Buy |
74
+64
| +640% | +$1.45K | ﹤0.01% | 4433 |
|
|
2020
Q2 | $23K | Sell |
10
-237
| -96% | -$5.24K | ﹤0.01% | 6113 |
|
|
2020
Q1 | $444K | Sell |
247
-360
| -59% | -$7.57K | ﹤0.01% | 2723 |
|
|
2019
Q4 | $1.44M | Buy |
607
+245
| +68% | +$5.95K | ﹤0.01% | 1764 |
|
|
2019
Q3 | $994K | Buy |
362
+19
| +6% | +$563 | ﹤0.01% | 1936 |
|
|
2019
Q2 | $1.13M | Buy |
343
+59
| +21% | +$2.02K | ﹤0.01% | 1794 |
|
|
2019
Q1 | $995K | Sell |
284
-126
| -31% | -$4.69K | ﹤0.01% | 2001 |
|
|
2018
Q4 | $1.36M | Buy |
410
+11
| +3% | +$473 | ﹤0.01% | 1373 |
|
|
2018
Q3 | $2.01M | Buy |
399
+173
| +77% | +$8.54K | 0.01% | 1243 |
|
|
2018
Q2 | $1.35M | Buy |
226
+15
| +7% | +$777 | 0.01% | 1500 |
|
|
2018
Q1 | $12K | Sell |
211
-26
| -11% | -$1.08K | ﹤0.01% | 3885 |
|
|
2017
Q4 | $57K | Buy |
237
+116
| +96% | +$4.58K | ﹤0.01% | 2320 |
|
|
2017
Q3 | $40K | Sell |
121
-56
| -32% | -$2.42K | ﹤0.01% | 2518 |
|
|
2017
Q2 | $3K | Buy |
177
+26
| +17% | +$925 | ﹤0.01% | 5039 |
|
|
2017
Q1 | $13K | Buy |
+151
| New | +$4.05K | ﹤0.01% | 3735 |
|
|
2016
Q4 | – | Sell |
-61
| Closed | -$24K | – | 6495 |
|
|
2016
Q3 | $24K | Sell |
61
-161
| -73% | -$3.64K | ﹤0.01% | 2805 |
|
|
2016
Q2 | $43K | Sell |
222
-117
| -35% | -$2.08K | ﹤0.01% | 2201 |
|
|
2016
Q1 | $27K | Buy |
+339
| New | +$4.42K | ﹤0.01% | 2520 |
|
|
2015
Q1 | – | Sell |
-30
| Closed | -$6K | – | 5561 |
|
|
2014
Q4 | $6K | Buy |
+30
| New | +$252 | ﹤0.01% | 2978 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
Simplex Trading's SUPN Position: Q1 2026 in Review
Simplex Trading opened a new position in Supernus Pharmaceuticals (SUPN) in Q1 2026: 2,850 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #4651 among its holdings. This is a return to the name: Simplex Trading previously reported a position in SUPN as recently as Q3 2025.
Simplex Trading first reported a position in SUPN in Q2 2016 and has held it in 25 quarters since. The position peaked at $941K in Q4 2019. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.
- Simplex Trading held 2,850 shares of Supernus Pharmaceuticals worth $147K as of Q1 2026.
- Supernus Pharmaceuticals was a new Simplex Trading position in Q1 2026.
- Supernus Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4651 holding.
- Simplex Trading first reported a position in Supernus Pharmaceuticals in Q2 2016 and has held it in 25 quarters since.
- Simplex Trading's Supernus Pharmaceuticals position peaked at $941K in Q4 2019.
- 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.